MOTHER3SENSE Study (MOTHER3SENSE)

June 11, 2026 updated by: Elif Simay KOÇ, Kilis 7 Aralik University

Effects of Maternal Voice, Touch, and Scent on Pain and Stress in Newborns: A Comparison of Three Sensory Interventions

This randomized controlled trial aims to compare the effects of maternal voice, touch, and scent on pain and stress levels in newborns during a routine heel lance procedure. Newborns will be randomly assigned to one of three intervention groups or a control group. Pain and stress responses will be assessed using validated neonatal pain and physiological measures. The findings of this study may help identify effective, low-cost, and non-pharmacological interventions that can be used to reduce pain and stress in newborns during routine clinical procedures.

Study Overview

Detailed Description

Painful procedures are frequently performed in newborns during routine clinical care and may lead to physiological and behavioral stress responses. Non-pharmacological interventions are recommended as safe and effective approaches for reducing procedural pain and stress in newborns. Maternal sensory stimuli, including maternal voice, touch, and scent, may provide comfort and support neonatal regulation during painful procedures.

This randomized controlled trial aims to compare the effects of maternal voice, maternal touch, and maternal scent on pain and stress responses in newborns undergoing a routine heel lance procedure. Eligible newborns will be randomly assigned to one of four groups: maternal voice, maternal touch, maternal scent, or control.

The assigned intervention will be applied according to a standardized protocol before, during, and after the heel lance procedure. Pain and stress responses will be assessed at three time points: before the procedure, during the procedure, and after the procedure. Behavioral and physiological indicators will be used to evaluate neonatal pain and stress responses.

The primary objective of the study is to determine and compare the effectiveness of maternal voice, touch, and scent in reducing procedural pain and stress in newborns. The findings may contribute to evidence-based, family-centered, and non-pharmacological pain management practices in neonatal care.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Term newborns born between 37 and 42 weeks of gestation
  • Newborns without respiratory, cardiac, metabolic, neurological, or infectious diseases
  • Newborns not requiring oxygen therapy, phototherapy, or intravenous treatment
  • Newborns scheduled to undergo a routine heel lance procedure (metabolic screening or blood sampling)
  • Mothers willing to participate in the study
  • Written informed consent provided by the parent or legal guardian
  • Normal vital signs before the procedure (heart rate, respiratory rate, and oxygen saturation within normal limits)

Exclusion Criteria:

  • Preterm (<37 weeks) or post-term (>42 weeks) newborns
  • Presence of congenital anomalies or neurological disorders
  • Requirement for oxygen therapy, phototherapy, or intravenous treatment
  • Respiratory, cardiac, metabolic, neurological, or infectious disease
  • Abnormal vital signs before the procedure
  • Parent or legal guardian refusal to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Maternal Voice
The recorded maternal voice will be presented to the newborn before, during, and after the procedure.
The recorded maternal voice will be presented to the newborn before, during, and after the procedure.
Experimental: Maternal Touch
The mother will maintain contact with the newborn's palms before, during, and after the procedure to stimulate the grasp reflex and provide tactile sensory input.
The mother will maintain contact with the newborn's palms before, during, and after the procedure to stimulate the grasp reflex and provide tactile sensory input.
Experimental: Maternal Scent
The newborn will be exposed to maternal breast milk scent during the procedure.
The newborn will be exposed to maternal breast milk scent during the procedure.
No Intervention: Control
Routine heel lance procedures will be performed, and no sensory intervention will be provided.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonatal Infant Pain Scale
Time Frame: Before the procedure, during the procedure, and immediately after the procedure
The Neonatal Infant Pain Scale (NIPS), originally developed by Lawrence et al. (1993), was adapted into Turkish by Akdovan (Akdovan & Yıldırım, 1999). NIPS is used to assess procedure-related pain in newborn infants. The scale evaluates five behavioral indicators-facial expression, crying, arm movements, leg movements, and state of arousal-as well as one physiological parameter, breathing pattern. Pain is assessed based on the evaluation of these behavioral and physiological responses.
Before the procedure, during the procedure, and immediately after the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Newborn stress scale
Time Frame: Before the procedure, during the procedure, and immediately after the procedure
The Newborn Stress Scale (NSS), developed by Ceylan and Bolışık, consists of 24 items rated on a 3-point Likert scale.
Before the procedure, during the procedure, and immediately after the procedure

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Newborn and Maternal Characteristics Form
Time Frame: At baseline
This researcher-developed form, based on the literature, was used to systematically collect demographic information about mothers and medical and birth-related characteristics of newborns.
At baseline
Neonatal Physiological Parameters Monitoring Form
Time Frame: Before the procedure, during the procedure, and immediately after the procedure
The Newborn Physiological Parameters Assessment Form was developed by the researchers based on the literature and was used to evaluate physiological parameters, including heart rate, oxygen saturation, and body temperature, before, during, and after the heel lance procedure.
Before the procedure, during the procedure, and immediately after the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

October 30, 2026

Study Registration Dates

First Submitted

June 11, 2026

First Submitted That Met QC Criteria

June 11, 2026

First Posted (Actual)

June 16, 2026

Study Record Updates

Last Update Posted (Actual)

June 16, 2026

Last Update Submitted That Met QC Criteria

June 11, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Kilis 7 Aralık Universty
  • MOTHER3SENSE Study (Other Identifier: Kilis 7 Aralık Universty)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress, Psychological

Clinical Trials on Maternal Voice

Subscribe